0001562180-23-000722.txt : 20230130
0001562180-23-000722.hdr.sgml : 20230130
20230130170207
ACCESSION NUMBER: 0001562180-23-000722
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230126
FILED AS OF DATE: 20230130
DATE AS OF CHANGE: 20230130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Reine Allan
CENTRAL INDEX KEY: 0001714023
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39634
FILM NUMBER: 23568726
MAIL ADDRESS:
STREET 1: C/O PIERIS PHARMACEUTICALS, INC.
STREET 2: 255 STATE STREET
CITY: BOSTON
STATE: MA
ZIP: 02109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Foghorn Therapeutics Inc.
CENTRAL INDEX KEY: 0001822462
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 TECHNOLOGY SQUARE
STREET 2: SUITE 700
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-586-3100
MAIL ADDRESS:
STREET 1: 500 TECHNOLOGY SQUARE
STREET 2: SUITE 700
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2023-01-26
false
0001822462
Foghorn Therapeutics Inc.
FHTX
0001714023
Reine Allan
500 TECHNOLOGY SQUARE
STE #700
CAMBRIDGE
MA
02139
false
true
false
false
Chief Financial Officer
Stock Option (right to buy)
8.38
2023-01-26
4
A
false
90000.00
0.00
A
2033-01-25
Common Stock
90000.00
90000.00
D
The option vests as to 25% of the underlying shares of common stock on January 26, 2024, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter.
/s /Adrian Gottschalk, Attorney-in-Fact for Allan Reine
2023-01-30